REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 80 filers reported holding REVANCE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,350,909 | -54.0% | 117,779 | +1.5% | 0.00% | -33.3% |
| Q2 2023 | $2,936,618 | +85416.0% | 116,026 | +8.8% | 0.00% | -25.0% |
| Q1 2023 | $3,434 | +81.2% | 106,611 | +3.9% | 0.00% | +33.3% |
| Q4 2022 | $1,895 | -99.9% | 102,650 | +10.8% | 0.00% | -25.0% |
| Q3 2022 | $2,501,000 | +116.9% | 92,638 | +11.0% | 0.00% | +100.0% |
| Q2 2022 | $1,153,000 | -26.9% | 83,443 | +3.1% | 0.00% | 0.0% |
| Q1 2022 | $1,578,000 | +18.4% | 80,902 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $1,333,000 | -44.0% | 81,661 | -4.5% | 0.00% | -33.3% |
| Q3 2021 | $2,381,000 | -2.6% | 85,476 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $2,444,000 | -1.0% | 82,463 | -6.6% | 0.00% | 0.0% |
| Q1 2021 | $2,469,000 | -9.1% | 88,329 | -7.8% | 0.00% | -25.0% |
| Q4 2020 | $2,716,000 | +23.0% | 95,821 | +9.1% | 0.00% | +33.3% |
| Q3 2020 | $2,208,000 | -11.4% | 87,813 | -14.0% | 0.00% | -25.0% |
| Q2 2020 | $2,492,000 | +106.6% | 102,065 | +25.3% | 0.00% | +33.3% |
| Q1 2020 | $1,206,000 | +9.4% | 81,468 | +20.0% | 0.00% | +50.0% |
| Q4 2019 | $1,102,000 | +27.1% | 67,891 | +1.9% | 0.00% | 0.0% |
| Q3 2019 | $867,000 | +5.5% | 66,654 | +5.1% | 0.00% | 0.0% |
| Q2 2019 | $822,000 | +6.2% | 63,396 | +29.1% | 0.00% | +100.0% |
| Q1 2019 | $774,000 | -11.2% | 49,124 | +13.3% | 0.00% | -50.0% |
| Q4 2018 | $872,000 | +19.6% | 43,339 | +47.8% | 0.00% | +100.0% |
| Q3 2018 | $729,000 | -15.5% | 29,328 | -6.8% | 0.00% | -50.0% |
| Q2 2018 | $863,000 | +16.0% | 31,453 | +30.2% | 0.00% | 0.0% |
| Q1 2018 | $744,000 | -2.2% | 24,166 | +13.6% | 0.00% | 0.0% |
| Q4 2017 | $761,000 | +7.9% | 21,276 | -16.9% | 0.00% | 0.0% |
| Q3 2017 | $705,000 | +5.4% | 25,603 | +1.1% | 0.00% | 0.0% |
| Q2 2017 | $669,000 | +40.3% | 25,333 | +10.4% | 0.00% | +100.0% |
| Q1 2017 | $477,000 | +9.9% | 22,938 | +9.3% | 0.00% | 0.0% |
| Q4 2016 | $434,000 | +37.8% | 20,986 | +8.0% | 0.00% | 0.0% |
| Q3 2016 | $315,000 | +21.6% | 19,430 | +2.1% | 0.00% | 0.0% |
| Q2 2016 | $259,000 | -10.7% | 19,030 | +14.6% | 0.00% | 0.0% |
| Q1 2016 | $290,000 | -47.0% | 16,610 | +3.7% | 0.00% | -50.0% |
| Q4 2015 | $547,000 | +32.8% | 16,020 | +15.7% | 0.00% | +100.0% |
| Q3 2015 | $412,000 | -3.1% | 13,850 | +4.1% | 0.00% | 0.0% |
| Q2 2015 | $425,000 | +99.5% | 13,299 | +112.0% | 0.00% | 0.0% |
| Q2 2014 | $213,000 | – | 6,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |